4//SEC Filing
LaFrance Norman D. 4
Accession 0001209191-09-026568
CIK 0001340752other
Filed
May 13, 8:00 PM ET
Accepted
May 14, 2:53 PM ET
Size
12.8 KB
Accession
0001209191-09-026568
Insider Transaction Report
Form 4
LaFrance Norman D.
Sr. VP Clinical Dev and CMO
Transactions
- Award
Employee Stock Option (right to buy)
2009-05-12+60,000→ 60,000 totalExercise: $3.93Exp: 2019-05-12→ Common Stock (60,000 underlying) - Award
Employee Stock Option (right to buy)
2009-05-12+30,000→ 30,000 totalExercise: $3.93Exp: 2019-05-12→ Common Stock (30,000 underlying)
Footnotes (2)
- [F1]This option vests and becomes exercisable in four equal annual installments of 15,000 shares each, beginning on May 12, 2010.
- [F2]This option vests and becomes exercisable in two equal annual installments of 15,000 shares each, beginning on May 12, 2010.
Issuer
Molecular Insight Pharmaceuticals, Inc.
CIK 0001340752
Entity typeother
Related Parties
1- filerCIK 0001397768
Filing Metadata
- Form type
- 4
- Filed
- May 13, 8:00 PM ET
- Accepted
- May 14, 2:53 PM ET
- Size
- 12.8 KB